Roche commits $750m to double Oregon-based US manufacturing capacity
Roche-owned Genentech has tapped the Northwestern state of Oregon as home to a new, $750m injectable manufacturing facility – expanding…
21 Aug 2026
Eli Lilly’s weekly insulin jab Onswik set for NHS use if approved
The UK’s National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for Eli Lilly’s Onswik (efsitora alfa) in a move that opens the insulin jab up…
21 Aug 2026
WellSpan and Johns Hopkins renew partnership for advanced cancer care access
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US. The development…
21 Aug 2026
Charles River and MVC to develop enterovirus vaccine
Charles River Laboratories International and Medigen Vaccine Biologics (MVC) have entered a collaboration to support the characterisation along with validation of the virus seed bank for the latter’s next-generation multivalent…
20 Aug 2026
Regeneron’s Pasatru wins FDA approval in ultra-rare ‘stone man disease’
Regeneron has won US Food and Drug Administration (FDA) approval for Pasatru (garetosmab-grts) in a rare connective tissue disorder, placing it in direct competition with Ipsen’s Sohonos (palovarotene). Pasatru is…
20 Aug 2026
Kynexis pockets €97m to advance cognition-focused schizophrenia drug
Dutch biotech Kynexis has banked €97m ($113m) through an extended Series A funding round, which the company will use to support the mid-to-late-stage development efforts for its lead cognitive disorder…
20 Aug 2026
FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
Ultragenyx Pharmaceutical has received accelerated approval from the US Food and Drug Administration (FDA) for its gene therapy, Genglycos (pariglasgene brecaparvovec-opnr), to treat glycogen storage disease type Ia (GSDIa). The…